Cancer treatment has entered a revolutionary phase with advancements in immunotherapy, a field that employs the immune system ...

Laboratory testing must be done before donated blood ever makes it to the hospital. Tests are conducted to make sure donated ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Shanghai Ark Biopharmaceutical (ArkBio) has concluded enrolment and dosing for a Phase I trial of fully human monoclonal ...

The following is a summary of “Suppressed HIV antibody responses following exposure to antiretrovirals—evidence from PrEP randomized trials and early antiretroviral treatment initiation studies,” ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...